Browsing Centre for Clinical Pharmacology by Subject "ASCOT"
Now showing items 1-1 of 1
-
Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
(Oxford University Press, 2024-01-31)BACKGROUND AND AIMS: Visit-to-visit systolic blood pressure variability (BPV) is an important predictor of cardiovascular (CV) outcomes. The long-term effect of a period of blood pressure (BP) control, but with differential ...